Ationdo SR 150mg tablets
BNF presentation 0407020AGBCADAE within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0407020AGBCADAE
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
442
NHS spend (£)
£17,592.73
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 89 |
| December 2024 | 32 |
| November 2024 | 98 |
| October 2024 | 99 |
| August 2024 | 6 |
| July 2024 | 90 |
| May 2024 | 28 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 18 | No data available |
| Unknown pharmacy | 14 | No data available |
| Unknown pharmacy | 14 | No data available |
| Unknown pharmacy | 13 | No data available |
| Unknown pharmacy | 13 | No data available |
| Unknown pharmacy | 11 | No data available |
| Unknown pharmacy | 10 | No data available |
| Unknown pharmacy | 10 | No data available |
| Unknown pharmacy | 10 | No data available |
| Unknown pharmacy | 9 | No data available |